
Sign up to save your podcasts
Or
Alzheimer’s disease is a devastating neurodegenerative condition that affects the entire family. As psychiatrists and psychologists, we often support these patients and their families throughout this entire disease process. With the recent and controversial FDA approval of aducanumab (Aduhelm™), a new pharmacotherapy for Alzheimer’s disease, we can expect to be asked about this drug from our patients and their family.
By listening to this episode, you can earn 1 Psychiatry CME Credits.
Link to blog.
Link to YouTube video.
4.8
12501,250 ratings
Alzheimer’s disease is a devastating neurodegenerative condition that affects the entire family. As psychiatrists and psychologists, we often support these patients and their families throughout this entire disease process. With the recent and controversial FDA approval of aducanumab (Aduhelm™), a new pharmacotherapy for Alzheimer’s disease, we can expect to be asked about this drug from our patients and their family.
By listening to this episode, you can earn 1 Psychiatry CME Credits.
Link to blog.
Link to YouTube video.
129 Listeners
193 Listeners
684 Listeners
617 Listeners
1,387 Listeners
148 Listeners
716 Listeners
289 Listeners
146 Listeners
557 Listeners
465 Listeners
691 Listeners
129 Listeners
156 Listeners
112 Listeners